XML 56 R45.htm IDEA: XBRL DOCUMENT v3.21.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2020
Stockholders Equity [Line Items]  
Schedule of share-based compensation expense

Year ended December 31, 

    

2020

    

2019

Employee Awards

$

1,411,442

$

3,880,938

Consulting Awards

 

92,947

 

85,683

$

1,504,389

$

3,966,621

Schedule of defined benefit plan, assumptions

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.95

$

0.95

Exercise price

$

2.35

$

1.00

Risk-free interest rate

 

2.21

%  

 

2.21

%

Expected dividend yield

 

 

Expected term (in years)

 

0.89

 

0.89

Expected volatility

 

123

%  

 

123

%

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.70

$

0.70

Exercise price

$

1.00

$

0.68

Risk-free interest rate

 

1.55

%  

 

1.55

%

Expected dividend yield

 

 

Expected term (in years)

 

0.47

 

0.47

Expected volatility

 

114

%  

 

114

%

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.67

$

0.67

Exercise price

$

0.68

$

0.45

Risk-free interest rate

 

1.61

%  

 

1.61

%

Expected dividend yield

 

 

Expected term (in years)

 

0.36

 

0.36

Expected volatility

 

113

%  

 

113

%

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.55

$

0.55

Exercise price

$

0.45

$

0.40

Risk-free interest rate

 

0.18 - 0.22

%  

 

0.18 - 0.22

%

Expected dividend yield

 

 

Expected term (in years)

 

0.60 - 2.60

 

0.60 - 2.60

Expected volatility

 

88 - 116

%  

 

88 - 116

%

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.70

$

0.70

Exercise price

$

1.00

$

0.68

Risk-free interest rate

 

1.55

%  

 

1.55

%

Expected dividend yield

 

 

Expected term (in years)

 

4.58

 

4.58

Expected volatility

 

114

%  

 

114

%

    

Pre-Trigger

    

Post-Trigger

 

Current stock price

$

0.67

$

0.67

Exercise price

$

0.68

$

0.45

Risk-free interest rate

 

1.61

%  

 

1.61

%

Expected dividend yield

 

 

Expected term (in years)

 

4.47

 

4.47

Expected volatility

 

113

%  

 

113

%

Schedule of stockholders' equity note, warrants or rights

Weighted-  

Weighted- 

Average

Average

Remaining

Number of

Exercise Price

Contractual 

Aggregate 

    

 Shares

    

per Share

    

Term (in years)

    

Intrinsic Value

Outstanding as of December 31, 2019

10,883,780

$

1.28

5.4

$

61,000

Granted

2,084,520

0.45

  

  

Exercised

 

 

 

  

 

  

Forfeited or expired

 

(5,701,880)

 

1.29

 

  

 

  

Outstanding as of December 31, 2020

 

7,266,420

 

$

1.03

 

5.9

$

176,000

Exercisable as of December 31, 2020

 

5,390,600

$

1.28

 

5.8

$

57,000

Weighted-

Weighted-

average

average

Remaining

Number of

Exercise Price

Contractual

Aggregate

    

Shares

    

per Share

    

Term (in years)

    

Intrinsic Value

Outstanding as of December 31, 2019

 

125,000

$

1.79

 

  

  

Granted

 

10,000

 

0.61

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited or expired

 

(35,000)

 

3.08

 

  

 

  

Outstanding and exercisable as of December 31, 2020

100,000

$

1.22

 

2.2

$

    

    

    

Weighted- 

    

Weighted-

average 

average 

Remaining 

Number of 

Exercise Price 

Contractual

Aggregate 

Shares

per Share

Term (in years)

Intrinsic Value

Outstanding as of December 31, 2018

 

5,992,214

$

2.26

 

  

 

  

Granted

 

2,481,000

 

0.98

 

  

 

  

Exercised

 

 

 

  

 

  

Expired

 

 

 

  

 

  

Outstanding as of December 31, 2019

 

8,473,214

 

0.64

 

0.5

 

$

1,169,583

Granted

 

7,143,011

 

0.42

 

  

 

  

Exercised

 

(1,131,000)

 

0.40

 

  

 

  

Expired

 

(7,064,214)

 

0.63

 

  

 

  

Outstanding and exercisable as of December 31, 2020

7,421,011

$

0.46

 

2.0

$

478,925

Employee Awards [Member]  
Stockholders Equity [Line Items]  
Schedule of defined benefit plan, assumptions

Year ended December 31, 

 

    

2020

    

2019

 

Exercise price

$

0.31 - 0.67

$

0.55 - 2.37

Stock price on date of grant

$

0.27 - 0.67

$

0.55 - 2.37

Volatility

 

111 - 114

%  

 

119 - 130

%

Risk-free interest rate

 

0.16 - 1.53

%  

 

1.43 - 2.60

%

Expected life (years)

 

3.0

 

3.0

Dividend yield

 

 

Year ended December 31, 

 

    

2020

    

2019

 

Exercise price

$

0.61

$

0.71 - 2.37

Stock price, date of valuation

$

0.61

$

0.71 - 2.37

Volatility

 

101

%  

 

125 - 141

%

Risk-free interest rate

 

1.47

%  

 

1.64 - 2.62

%

Expected life (years)

 

1.0

 

2.0 - 5.0

Dividend yield

 

 

Feinsod Agreement [Member]  
Stockholders Equity [Line Items]  
Schedule of defined benefit plan, assumptions

    

August 6, 2020

 

Current stock price

$

0.83

Exercise price

$

0.83

Vesting goal

$

4.51

Risk-free interest rate

 

1.73

%

Expected term (in years)

 

10

Expected volatility

 

123

%